Fate Therapeutics, Inc. (FATE) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.28
Day's range
$1.38

Fate Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
REDMILE GROUP, LLC 02/17/2026 12.87 M $12.65 M   0.00% 10.82%
BLACKROCK, INC. 02/12/2026 10.18 M $10.00 M   -4.72% 8.55%
VANGUARD GROUP INC 01/29/2026 8.97 M $8.82 M   1.96% 7.54%
JOHNSON & JOHNSON 03/18/2026 3.38 M $3.32 M   0.00% 2.84%
ACADIAN ASSET MANAGEMENT LLC 02/10/2026 2.93 M $2.88 M   8.18% 2.46%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 2.47 M $2.43 M   -2.45% 2.07%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 2.36 M $2.32 M   87.00% 1.98%
STATE STREET CORP 02/13/2026 2.27 M $2.23 M   -6.29% 1.90%
TWO SIGMA INVESTMENTS, LP 02/17/2026 1.73 M $1.70 M   92.51% 1.46%
VESTAL POINT CAPITAL, LP 02/17/2026 1.73 M $1.69 M   -31.41% 1.45%
TWO SIGMA ADVISERS, LP 02/17/2026 1.65 M $1.62 M   63.96% 1.39%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 1.58 M $1.55 M   -24.70% 1.33%
POINT72 ASSET MANAGEMENT, L.P. 02/17/2026 1.53 M $1.50 M   100.00% 1.28%
GOLDMAN SACHS GROUP INC 03/25/2026 1.44 M $1.41 M   -3.46% 1.21%
TANG CAPITAL MANAGEMENT LLC 02/17/2026 1.17 M $1.15 M   -37.48% 0.98%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 1.16 M $1.14 M   2.70% 0.98%
MORGAN STANLEY 02/13/2026 916.95 K $900.99 K   -1.40% 0.77%
JANE STREET GROUP, LLC 02/12/2026 842.81 K $828.14 K   39.59% 0.71%
MONACO ASSET MANAGEMENT SAM 02/10/2026 830.00 K $815.56 K   7.79% 0.70%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 784.63 K $770.98 K   -0.16% 0.66%
CITADEL ADVISORS LLC 02/17/2026 749.34 K $736.30 K   -9.12% 0.63%
NORTHERN TRUST CORP 02/17/2026 732.67 K $719.92 K   -10.04% 0.62%
BRUCE & CO., INC. 02/13/2026 729.19 K $716.50 K   0.00% 0.61%
DAFNA CAPITAL MANAGEMENT LLC 02/17/2026 550.00 K $540.43 K   100.00% 0.46%
MILLENNIUM MANAGEMENT LLC 02/17/2026 522.62 K $513.52 K   -45.78% 0.44%
UBS GROUP AG 01/29/2026 403.52 K $396.66 K   28.20% 0.34%
INVESCO LTD. 02/19/2026 379.03 K $372.43 K   20.39% 0.32%
PRIVIUM FUND MANAGEMENT B.V. 02/03/2026 369.10 K $362.68 K   10.77% 0.31%
KNOTT DAVID M JR 02/12/2026 365.00 K $358.65 K   0.00% 0.31%
XTX TOPCO LTD 02/17/2026 364.74 K $358.39 K   -16.71% 0.31%
WOODLINE PARTNERS LP 02/17/2026 356.65 K $350.44 K   -49.95% 0.30%
NUVEEN, LLC 02/12/2026 336.87 K $331.01 K   0.00% 0.28%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 310.19 K $304.79 K   73.36% 0.26%
BARCLAYS PLC 02/13/2026 308.54 K $303.17 K   46.58% 0.26%
BANK OF NEW YORK MELLON CORP 02/10/2026 307.60 K $302.25 K   -2.76% 0.26%
QUADRATURE CAPITAL LTD 02/17/2026 298.08 K $292.90 K   -21.01% 0.25%
MAN GROUP PLC 02/17/2026 261.17 K $256.63 K   18.90% 0.22%
GSA CAPITAL PARTNERS LLP 02/06/2026 213.65 K $210.00 K   -31.27% 0.18%
GRAHAM CAPITAL MANAGEMENT, L.P. 02/17/2026 195.58 K $192.18 K   -58.31% 0.16%
SCHONFELD STRATEGIC ADVISORS LLC 02/17/2026 192.68 K $189.33 K   -64.62% 0.16%
ALLIANCEBERNSTEIN L.P. 02/17/2026 187.70 K $184.43 K   0.00% 0.16%
WELLS FARGO & COMPANY/MN 02/13/2026 172.28 K $169.29 K   28.72% 0.14%
BANK OF AMERICA CORP /DE/ 02/17/2026 151.11 K $148.39 K   3.11% 0.13%
ASSENAGON ASSET MANAGEMENT S.A. 01/09/2026 148.65 K $146.07 K   1.93% 0.12%
RHUMBLINE ADVISERS 02/13/2026 146.76 K $144.25 K   -4.75% 0.12%
LPL FINANCIAL LLC 02/11/2026 144.82 K $142.30 K   505.52% 0.12%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 02/17/2026 135.00 K $132.65 K   35.00% 0.11%
IEQ CAPITAL, LLC 02/13/2026 121.50 K $119.39 K   -11.67% 0.10%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2026 111.23 K $109.29 K   100.00% 0.09%
HSBC HOLDINGS PLC 03/20/2026 97.68 K $96.24 K   -0.12% 0.08%

Fate Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 230 institutional investors and hedge funds held shares of Fate Therapeutics Inc. The most heavily invested institutionals were:

UBS Group AG: 1.82 M

DIMENSIONAL FUND ADVISORS LP: 883,790

Monaco Asset Management SAM: 810,000

VANGUARD FIDUCIARY TRUST CO: 653,761

JANE STREET GROUP, LLC: 646,979

Connor, Clark & Lunn Investment Management Ltd.: 469,785

60.51% of Fate Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 106.57 M shares in the last 24 months. This purchase volume represents approximately $141.74 M in transactions.